First human test: how does a bad liver handle a new drug?
NCT ID NCT07165002
Summary
This is an early safety study to understand how a new drug, LY3537031, is processed by the body in people with different levels of liver function. It will enroll 32 people, including healthy volunteers and those with mild, moderate, or severe liver impairment. The main goal is to measure how much of the drug gets into the blood and how long it stays there after a single injection under the skin.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Research Units Hungary
RECRUITINGKistarcsa, H-243, Hungary
Contact Phone: •••-•••-••••
Contact
-
New Zealand Clinical Research Auckland
RECRUITINGAuckland, 1010, New Zealand
Contact Phone: •••-•••-••••
Contact
-
Summit Clinical Research, s.r.o. - Bratislava
RECRUITINGBratislava, 831 01, Slovakia
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.